Leukemia Archives - Page 3 Of 5

Inotuzumab Ozogamicin for Injection

inotuzumab ozogamicin for injection,
for intravenous use Initial U.S. Approval: 2017

Besponsa (inotuzumab ozogamicin) is is a medication used for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Facts about inotuzumab ozogamicin for injection

Disease Indications-Leukemia
Manufacturer-Pfizer Limited
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “inotuzumab ozogamicin for injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Ivosidenib Tablets

Leukemia, Bile Duct Cancer, Gastrointestinal

Ivosidenib tablets
for oral use Initial U.S. Approval: 2018

Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have: Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, or Locally advanced or metastatic bile duct cancer (cholangiocarcinoma).

Facts about ivosidenib tablets

Disease Indications-Leukemia, Bile Duct Cancer
Manufacturer-Servier Pharmaceuticals
Usage-Oral
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ivosidenib Tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

JYLAMVO (methotrexate) oral

Arthritis, Leukemia, Lymphoma

Brand Name: JYLAMVO Generic Name: methotrexate . JYLAMVO (methotrexate) is used to treat ALL, mycosis fungoides, nonHodgkin lymphoma, rheumatoid arthritis and severe psoriasis.

JYLAMVO is a folate analog metabolic inhibitor indicated for the: • Treatment of adults with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen • Treatment of adults with mycosis fungoides • Treatment of adults with relapsed or refractory nonHodgkin lymphoma as part of a metronomic combination regimen • Treatment of adults with rheumatoid arthritis • Treatment of adults with severe psoriasis.

Brand Name:	JYLAMVO
Generic Name:	methotrexate
Strength:	Oral solution: 2 mg/mL
Manufacturer:	Therakind Limited
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “JYLAMVO (methotrexate)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for JYLAMVO (methotrexate) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

KOMZIFTI (ziftomenib) capsules

Leukemia

midostaurin capsules

Leukemia

midostaurin capsules
for oral use Initial U.S. Approval: 2017

Rydapt (midostaurin) is a medication used for the treatment of patients with newly diagnosed acute myeloid leukemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).

Facts about midostaurin capsules

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Novartis Europharm Limited
USAGE-Oral
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “midostaurin capsules” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

moxetumomab pasudotox-tdfk for injection

Leukemia

moxetumomab pasudotox-tdfk for injection
for intravenous use Initial U.S. Approval: 2018

Lumoxiti (moxetumomab pasudotox) is a CD22-directed cytotoxin indicated for adult patients with advanced hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA).

Facts about moxetumomab pasudotox-tdfk for injection

DISEASE INDICATIONS-Leukemia
MANUFACTURER-AstraZeneca Pharmaceuticals LP
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA)

Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Full Support:

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Nilotinib Capsules

Leukemia

nilotinib Capsules
for oral use Initial U.S. Approval: 2007

Tasigna (nilotinib) is a prescription medicine used to treat chronic myelogenous leukaemia (CML) in patients who have the Philadelphia chromosome. It may be used in people who have been newly diagnosed or who cannot take other cancer medicines (including imatinib).

Facts about nilotinib Capsules

Disease Indications-Leukemia
Manufacturer-Novartis
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Nilotinib Capsules” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Obinutuzumab Injection

Leukemia

obinutuzumab injection
for intravenous use Initial U.S. Approval: 2013

Facts about obinutuzumab injection

Approval Date: 2013
Proprietary Name: On Request
Active Ingredient(s): obinutuzumab
Dosage Forms And Strengths: 1000 mg/40 mL (25 mg/mL) single-dose vial.
Company: Roche
Current indications: chronic lymphocytic leukemia; follicular lymphoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “obinutuzumab injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Pegaspargase injection

Leukemia

Pegaspargase injection, for intramuscular or intravenous use. Initial U.S. Approval: 1994

Generic Name – Pegaspargase injection
Medicine Type – Injection / Intrevenous
Manufacturer Name – Servier IP UK Ltd
Approval Year – 2006
Approved by – Food and Drug Administration (FDA)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import pegaspargase injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Ponatinib tablets

Leukemia

Ponatinib injection
for subcutaneous use Initial U.S. Approval: 2012

Ponatinib tablets is “used to treat patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Ph+ ALL for whom no other tyrosine kinase inhibitor (TKI)“. ICLUSIG Tablets is a “prescription medicine”. It is available in “form and strength” Tablets: 15 mg and 45 mg. ICLUSIG Tablets can be obtained in India upon request.
To inquire about the ICLUSIG (ponatinib) tablets“offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”

Facts about your medicine

Approval Date: 2012
Proprietary Name: On Request
Active Ingredient(s): Ponatinib tablets
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ponatinib tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Leukemia

inotuzumab ozogamicin for injection, for intravenous use Initial U.S. Approval: 2017

Facts about inotuzumab ozogamicin for injection

Access the best support services globally

Ivosidenib tablets for oral use Initial U.S. Approval: 2018

Facts about ivosidenib tablets

Access the best support services globally

Brand Name: JYLAMVO Generic Name: methotrexate . JYLAMVO (methotrexate) is used to treat ALL, mycosis fungoides, nonHodgkin lymphoma, rheumatoid arthritis and severe psoriasis.

midostaurin capsules for oral use Initial U.S. Approval: 2017

Facts about midostaurin capsules

Access the best support services globally

moxetumomab pasudotox-tdfk for injection for intravenous use Initial U.S. Approval: 2018

Facts about moxetumomab pasudotox-tdfk for injection

Full Support:

nilotinib Capsules for oral use Initial U.S. Approval: 2007

Facts about nilotinib Capsules

Access the best support services globally

obinutuzumab injection for intravenous use Initial U.S. Approval: 2013

Facts about obinutuzumab injection

Access the best support services globally

Pegaspargase injection, for intramuscular or intravenous use. Initial U.S. Approval: 1994

Access the best support services globally

Ponatinib injection for subcutaneous use Initial U.S. Approval: 2012

Facts about your medicine

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

inotuzumab ozogamicin for injection,
for intravenous use Initial U.S. Approval: 2017

Ivosidenib tablets
for oral use Initial U.S. Approval: 2018

midostaurin capsules
for oral use Initial U.S. Approval: 2017

moxetumomab pasudotox-tdfk for injection
for intravenous use Initial U.S. Approval: 2018

nilotinib Capsules
for oral use Initial U.S. Approval: 2007

obinutuzumab injection
for intravenous use Initial U.S. Approval: 2013

Ponatinib injection
for subcutaneous use Initial U.S. Approval: 2012